OXiGENE (OXGN) Files $40M Mixed Shelf
OXiGENE (Nasdaq: OXGN) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $40 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Rights, Purchase Contracts, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merrill Lynch Will Pay $415M to Settle SEC Investigation (BAC)
- Eiger BioPharmaceuticals (EIGR) Enters $25M Stock Sales Agreement
- Cyclacel Pharma (CYCC) Enters $4M At Market Issuance Sales Agreement
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!